TRUISM
2 weeks ago
Bolt Projects Reports Q3 2024 Financial Results
Thu, November 7, 2024, 4:30 PM EST
LINK
Vegan Silk Traction Drives Third Quarter Results
* Full year 2024 b-silk™ revenues are projected to exceed $1 million, propelled by deeper segment penetration and growing customers and consumers adoption
* For 2025, b-silk revenues are projected to reach at least $4.5 million, bolstered by new customer acquisition
* Our 2024 COGS reduction program has delivered over 60% in cost-per-kilogram produced reduction for b-silk for the year, following on prior year gains
* Continued operational efficiencies and additional COGS reduction to create a path toward the goal of long-term, sustainable profitability
November 07, 2024--(BUSINESS WIRE)--Bolt Projects Holdings, Inc. ("Bolt," "Bolt Projects" or the "Company") (Nasdaq: BSLK), which develops and produces innovative biomaterials for the beauty and personal care industry, reported its financial results for the third quarter ended September 30, 2024 and provided a business update. In addition, the Company’s Third Quarter 2024 Shareholder Letter can be found on Bolt Projects’ Investor Relations website at https://www.boltprojectsholdings.com/.
"Over the past eighteen months, Bolt has undergone a transformational change toward a sustainable and efficient business model focused on replacing harmful environmental materials with sustainable, high-performance alternatives in the beauty and personal care market," said Dan Widmaier, Bolt Projects Chairman and CEO.
"The cornerstone of this strategy is our commercially ready b-silk™ technology, which has been on the market since 2019 and in multiple products within the beauty industry. As we have continued to work through the sales funnel we are seeing accelerated traction with prospects who want to use biotechnology ingredients to drive the products of the future."
"We believe that Bolt is entering the market at an optimal time for market expansion, as companies have been facing aggressive environmental targets and regulatory restrictions, particularly around the biodegradability of materials used in their processes," said Bolt Projects President Cintia Nardi. "Bolt’s sustainable biomaterials have the ability to meet these demands and drive a cleaner, more responsible future without sacrificing the high performance of their product offering."
Market Traction
"This effort has been led by b-silk, a revolutionary biodegradable, film-former polypeptide that offers additional functional benefits for hair care, skin care and color cosmetics," said Widmaier. "Since 2019, B-silk has delivered consistent and proven consumer satisfaction."
During the third quarter, two new products featuring b-silk – the Daily Defender SPF30 and the Peak Performance SPF50 – from Freaks of Nature™ were introduced to the market, driving higher visibility and deeper penetration in the sunscreen product type within skin care.
This launch adds to b-silk’s long-standing success in the hair care segment as part of Vegamour’s GRO Revitalizing Shampoo and Conditioner since 2020, powering their proprietary Karmatin™ offering. Vegamour’s success drove our revenue growth for multiple years, illustrating the impact new customer launches can have.
Bolt anticipates continued progress in multiple segments with established and indie ("independent") consumer brands launching new products into the global market featuring Bolt’s Vegan Silk Technology Platform.
During the third quarter, Bolt also launched a second proprietary product from its Vegan Silk Technology Platform under the trade name xl-silk and an exclusive b-silk serum ingredient.
Looking forward, the two launches currently anticipated for 2025 are:
As early as the first quarter of 2025, a cosmetics brand is scheduled to debut a color cosmetic offering that uses Bolt’s Vegan Silk Technology Platform. "We see this product expansion as a testament to our cutting-edge Vegan Silk Technology Platform, showcasing its novel functionality," said Nardi.
"This offering has the potential to set a new standard in the beauty industry by enabling high-performance formulations in this product type. We are excited about the potential of this collaboration and its market innovation."
Later in 2025, a separate cosmetics brand is slated to launch a professional haircare line using Bolt’s Vegan Silk Technology Platform. "This brand will feature an exclusive b-silk serum with unique, scientifically proven, functional benefits," said Nardi. "This innovation aims to bring true differentiation into the segment and to deliver substantial growth backed by a multi-year contract with an exciting new partner."
Bolt management expects to share information about additional customer launches in the coming year and will further showcase the potential of its Vegan Silk Technology Platform across segments of the beauty and personal care industry. "Overall, we believe 2025 will be pivotal in demonstrating the impact of our innovative technology as it is unveiled by our customers," said Widmaier.
"We anticipate new products that not only meet new and challenging regulatory rules around silicones and that can deliver compelling and differentiated benefits but also aim to meet the consumer’s desire for more sustainable materials."
"We aspire to be the most desirable biotech ingredient innovator for the beauty and personal care industry," said Widmaier, "and so we will continue relentlessly developing breakthrough innovations that surprise and delight the market, helping us gain meaningful market share, because we believe that ‘the best days are ahead of us’ and we believe the future is one ‘Where Doing Good Will Help Us Do Well.’"
Based on current planned and pending launches, Bolt anticipates deliveries in the fourth quarter will bring 2024 revenue over $1.0 million. For 2025, Bolt foresees significant acceleration of b-silk and xl-silk sales, with at least $4.5 million of revenue already committed in 2025.
Operational Scalability & Supply Chain Reliability
"Bolt recognizes that to accelerate adoption and market penetration, our product needs to be priced to reflect its biotech innovation while also supporting the cost structure of our brand partners," said Widmaier. "Bolt has implemented a clear plan for cost optimization through process improvements, strategic procurement, and volume-driven savings."
"We believe that these changes will position us to pursue our target margins and expand our market presence," said Nardi, "clearing a path to both profitability and competitive pricing."
These strategic efforts delivered unprecedented results for the company in 2024. Year-to-date, Bolt has manufactured more than 3,000 kilograms of vegan silk material with its contract-manufacturing (CMO) partner. "These runs exceeded our highest historical production runs by more than 50%, and cost per kilo for 2024 was reduced by over 60%, both strong results along the company’s path to becoming a free-cash-flow generating business," said Nardi.
Bolt continues to strengthen its partnership with its manufacturing network while strategically diversifying its supply chain to support business continuity and future growth. "The current capacity at our CMO partner comfortably meets our 2025 needs and projected year-over-year growth," said Nardi. "Additionally, with the completion of their newest facility, our biomanufacturing partner has significantly expanded its production capacity and enhanced our business continuity. This should better position us to continue scaling efficiently while providing greater production stability and fostering long-term growth potential."
"Beyond their efforts to establish reliable and efficient operational processes, our supply chain team has been focused on delivering excellent customer service and exceptional quality performance, all while maintaining a focus on a key attribute of our business and products – sustainability," said Nardi.
"Sustainability for both people and the planet is at the core of Bolt’s mission: ‘Way Better Materials for a Way Better World’," said Widmaier. "I am proud to share that in the third quarter, we reached a significant milestone for this aspect of our mission by being awarded the EcoVadis Silver Medal"." EcoVadis is a third-party rating organization that reviews approximately 73,000 companies each year.
"This accomplishment puts us in the top 15% of companies assessed globally for sustainability, and it underscores our dedication to ethical practices, environmental stewardship, and social impact, positioning us as a trusted partner for customers and a responsible investment opportunity for stakeholders."
Research and Development Delivers
While our focus in the past eighteen months has been optimizing Bolt’s operational processes and bolstering its go-to-market strategy, Bolt’s Research and Development effort continues to be the driving force of the company's unique value proposition, building on an intellectual property portfolio anchored by 64 granted patents and 170 pending patent applications.
"Our Vegan Silk Technology Platform has benefited from decades of advancements in silk and biomaterials research and 15 years of development at Bolt," said Chief Technology Officer David Breslauer. "Our breakthroughs have enabled the creation of b-silk and xl-silk, highly efficacious ingredients for the beauty and personal care industry.
These materials have been shown to deliver exceptional solutions to pressing regulatory constraints and consumer’s preferences, while enabling brands to deliver on their commitment to environmental health and sustainability."
Bolt’s focus on optimizing biomanufacturing processes, diversifying products, substantiating benefits and expanding its capabilities to support new product types has led to a number of wins over the past year, including:
Lower cost of manufacturing, a reduction of more than 60% per kg of b-silk produced in 2024
Multiple patent applications, trademark filings, and published papers
Development of five new molecules and two product extensions, all of which already have official INCI names (International Nomenclature Cosmetic Ingredient) assigned by the Personal Care Products Council (PCPC)
Bolt’s focus on efficiencies also extends to its research strategy, where external capabilities and infrastructure are situationally engaged, designed to capitalize on specific areas of expertise within the biotech ecosystem, such as our collaboration with Ginkgo Bioworks’ facilities and talent. This approach has enabled Bolt to deliver innovation without the significant upfront capital investment and taps into a large pool of technical talent.
Corporate Milestones
In addition to the progress above for b-silk, 2024 has seen a number of important steps forward for the Company. Notably, this earnings release represents its first following the completion of the business combination transaction between Golden Arrow Merger Corp. and the Bolt business. Over the course of the business combination, Bolt Projects closed on an aggregate of approximately $28 million PIPE and bridge financing, including $4.7 million in PIPE proceeds in August 2024, led by investors such as Scottish Mortgage / Baillie Gifford and Temasek, to support Bolt’s structure and increase its capital to advance its b-silk market expansion efforts.
Financial Results for the Third Quarter Ended September 30, 2024
Revenues. Revenues for the third quarter of 2024 were approximately $0.01 million compared to revenues of $1.3 million in the third quarter of 2023. Revenues decreased by $1.3 million for the three months ended September 30, 2024 compared to the three months ended September 30, 2023, primarily due to decreased sales of products from the Vegan Silk Technology Platform, including our b-silk product.
Third quarter revenues in 2023 were primarily comprised of sales to a brand as part of a broader supply and license agreement that resulted in volumes that met their projections for 2023 and 2024.
Third quarter revenues in 2024 were de minimus and related to sample volumes to support impending product launches.
Cost of Revenues. Cost of revenues for the third quarter of 2024 was approximately $0.01 million with a gross margin of 0.0%, compared to cost of revenues of $1.3 million for the third quarter of 2023 with a gross margin of 2.7%. Cost of revenues decreased by $1.3 million for the three months ended September 30, 2024 compared to the three months ended September 30, 2023, primarily due to the decrease of biomanufacturing costs relative to the decreased sales from our Vegan Silk Technology Platform, including our b-silk product.
Operating Expenses. Operating expenses were approximately $20.2 million in the third quarter of 2024, compared to $5.2 million for the same period in 2023. The primary increase was driven by transaction expenses and an increase in stock-based compensation expense related to the vesting of Restricted Stock Unit (RSU) grants related to the merger agreement with Golden Arrow Merger Corporation. In addition, the Company saw higher spending overall in operations to support growth of the business.
In research and development, increases were driven by the delivery of a new material (xl-silk) and a new formulation for b-silk in the Vegan Silk Technology Platform.
In sales and marketing, expenses decreased excluding stock-based compensation related to RSU grants, primarily due to a temporary suspension of our sales and marketing efforts during our capital raise.
In general and administrative, increases were caused by costs of becoming a public company, including consulting expenses and attendant public company requirements, as well as an increase in executive bonuses based on the completion of the merger transaction.
Operating and Net Income. Operating loss and net income were approximately $20.2 million and $6.4 million, respectively, for the third quarter of 2024, compared to operating loss and net loss of $5.1 million and $5.6 million, respectively, for the third quarter of 2023. Net income in the third quarter of 2024 is primarily driven by a gain related to the remeasurement gains on the Company’s warrant liabilities.
Adjusted EBITDA. Adjusted EBITDA was approximately ($2.8) million in the third quarter 2024, compared to ($4.1) million for the third quarter of 2023.
Earnings per Share. Basic earnings per share was $0.32 for the third quarter of 2024, compared to basic net loss per share of $1.80 for the third quarter of 2023.
Financial Outlook
Bolt Projects Holdings projects at least $1.0 million in revenues for 2024 and at least $4.5 million in revenues for 2025.
In addition, Bolt anticipates gross profit will be positive for the full year 2025.[/color]
TRUISM
2 weeks ago
11/7/24: Bolt Projects (BSLK) 8-KNotice Of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
LINK
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On November 6, 2024, Bolt Projects Holdings, Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).
The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Global Market.
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until May 5, 2025, to regain compliance with the Minimum Bid Price Requirement. If, at any time during this 180-day period, the closing bid price of the Company’s common stock is at least $1.00 for a minimum of ten consecutive business days, Nasdaq staff will provide written notification that the Company has achieved compliance with the Minimum Bid Price Requirement.
In the event the Company does not regain compliance with the Minimum Bid Price Requirement by May 5, 2025, the Company may be eligible for an additional 180-calendar-day compliance period. To qualify, the Company must submit an application to transfer to The Nasdaq Capital Market, which would require the Company to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement.
The Company would also need to pay an application fee to Nasdaq and provide written notice of its intention to cure the bid price deficiency during the second compliance period by effecting a reverse stock split if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq would notify the Company that its securities will be subject to delisting. In the event of such a notification, the Company may appeal the Nasdaq staff’s determination to delist its securities.
There can be no assurance that the Company would be afforded additional time to regain compliance with the Minimum Bid Price Requirement following the initial 180-day period, if needed, or that the Nasdaq staff would grant a request by the Company for continued listing subsequent to any delisting notification.
The Company intends to actively monitor the bid price of its common stock and may, if appropriate, consider taking actions to regain compliance with the Minimum Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will remain in compliance with other applicable Nasdaq listing rules.
TRUISM
4 weeks ago
10/5/23-Bolt Threads Plans To Go Public Via SPAC
By Laura Deppen
LINK
The announcement comes after the company struggled to raise funds for the production of its mushroom leather alternative.
Biomaterials maker Bolt Threads plans to become publicly traded through a special purpose acquisition company. Retrieved from Bolt Threads on October 05, 2023
Audio
Dive Brief:
* Biomaterials maker Bolt Threads plans to become publicly traded through a special purpose acquisition company, Bolt announced Wednesday in a press release.
* Bolt reached an agreement with Golden Arrow Merger Corp. The combined company will operate as Bolt Projects Holdings, Inc. and is expected to trade on the Nasdaq exchange as BSLK.
* The news comes after Bolt paused the production of its mushroom leather alternative, Mylo, after reportedly struggling to find funding. The material was used in Lululemon products, Stella McCartney and Adidas.
Dive Insight:
While Bolt faces competition in the leather alternative space from the likes of MycoWorks, which recently launched commercial-scale production of its mushroom-based material, it is leaning into its lead product b-silk, a biodegradable ingredient made from spider silk fibers in beauty and personal care products, which has been on the market since 2020. It also makes Microsilk, also made from spider silk fibers.
The transaction is expected to close in the first quarter of 2024. Dan Widmaier, Bolt Threads founder and CEO, will lead the combined company.
“Our mission remains steadfast to develop and provide better solutions for a way better world, and we believe that going public will allow us to grow our biomaterials platform and bring b-silk, among other products, to commercialization faster,” Widmaier said in the release. “Bringing low impact innovative materials to market is increasingly difficult and desperately needed.”
The deal is expected to generate $35 million in gross proceeds for the company. This creates an interim bridge financing of $6.8 million, and $5.5 million of which was funded toward the signing of the combination agreement, and $28.7 million in stock.
Founded in 2009, Bolt’s goal is to replace ingredients with more biodegradable options. It has 49 granted patents, and 171 pending patent applications, per the release.
TRUISM
4 weeks ago
10/22/24-Bolt Projects Holdings Announces More Brands Choosing B-Silk™ To Differentiate Their Product Offerings
Business Wire-Tue, October 22, 2024, 9:05 AM EDT
LINK
BERKELEY, Calif., October 22, 2024--(BUSINESS WIRE)--Over the past eighteen months, Bolt Projects Holdings [Nasdaq: BSLK] has undergone transformational change designed to accelerate penetration of its Vegan Silk Technology Platform into the beauty and personal care industry.
"This effort has been led by b-silk, a novel biodegradable, film-former polypeptide designed to offer additional functional benefits for haircare, skincare and color cosmetics," said Bolt Projects Holdings Chairman and CEO Dan Widmaier. "B-silk has been in the market since 2018 and has delivered consistent and proven consumer satisfaction."
During the third quarter of 2024, two new products featuring b-silk™ – the Daily Defender SPF30 and the Peak Performance SPF50 – from Freaks of Nature™ were introduced to the market, driving higher visibility and penetration in the sunscreen product type within skincare.
This launch adds to b-silk’s long-standing presence in the haircare segment since 2020 as part of Vegamour’s GRO Revitalizing Shampoo and Conditioner, powering their proprietary Karmatin™ offering. Vegamour’s success drove Bolt’s revenue growth for multiple years, resulting in 2023’s annual revenue of $3.4M, illustrating the building impact new customer launches can have.
Another launch featuring b-silk™ is expected as early as the first quarter of 2025. A cosmetics brand is slated to debut a color cosmetic product. "We see this product expansion as a testament to our cutting-edge Vegan Silk Technology Platform, showcasing its novel functionality," said Bolt Projects Holdings President Cintia Nardi. "This offering has the potential to set a new standard in the beauty industry and enable high-performance formulations in this product type. We are excited about the potential of this collaboration and the innovation it brings to the segment."
Bolt expects to share information about additional customer launches in the upcoming months and to showcase the potential of its Vegan Silk Technology Platform across many segments of the beauty and personal care industry. These launches will be supported in part by a second proprietary product from its Vegan Silk technology platform under the trade name xl-silk.
"Overall, we believe 2025 will be pivotal in demonstrating the impact of our innovative technology as it is unveiled by our customers’ new product launches," said Nardi. "This market innovation not only meets new and challenging regulatory rules around silicones but also targets consumers’ desire for efficacious products and more sustainable materials."
"We aspire to be the most desirable biotech ingredient innovator for the beauty and personal care industry," said Widmaier, "and so we will continue relentlessly pursuing market share because we believe that ‘the best days are ahead of us’ and we believe the future is one ‘Where Doing Good Will Help Us Do Well.’"
Bolt Projects Holdings will announce third quarter 2024 earnings on November 7, 2024 after market close.
TRUISM
4 weeks ago
10/17/24-BOLT PROJECTS HOLDINGS INC. (BSLK) SHARES RISE DESPITE MARKET CHALLENGES
BY Ethane Eddington
LINK
The stock price of Bolt Projects Holdings Inc. (NASDAQ: BSLK) has jumped by 14.73 compared to previous close of 0.49. Despite this, the company has seen a gain of 12.44% in its stock price over the last five trading days.
IS IT WORTH INVESTING IN BOLT PROJECT HOLDINGS INC. (NASDAQ: BSLK) RIGHT NOW?
BSLK has 36-month beta value of -0.17.
The average trading volume of BSLK on October 17, 2024 was 748.29K shares.
BSLK’S MARKET PERFORMANCE
BSLK’s stock has seen a 12.44% increase for the week, with a -51.11% drop in the past month and a -94.87% fall in the past quarter. The volatility ratio for the week is 22.06%, and the volatility levels for the past 30 days are at 13.42% for Bolt Projects Holdings Inc. The simple moving average for the past 20 days is -19.56% for BSLK’s stock, with a -93.45% simple moving average for the past 200 days.
BSLK TRADING AT -78.93% FROM THE 50-DAY MOVING AVERAGE
After a stumble in the market that brought BSLK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.70% of loss for the given period.
Volatility was left at 13.42%, however, over the last 30 days, the volatility rate increased by 22.06%, as shares sank -45.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -94.90% lower at present.
During the last 5 trading sessions, BSLK rose by +12.44%, which changed the moving average for the period of 200-days by -94.50% in comparison to the 20-day moving average, which settled at $0.6989. In addition, Bolt Projects Holdings Inc. saw -94.69% in overturn over a single year, with a tendency to cut further losses.
STOCK FUNDAMENTALS FOR BSLK
Equity return is now at value -0.96, with -24.18 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.
CONCLUSION
To put it simply, Bolt Projects Holdings Inc. (BSLK) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
TRUISM
1 month ago
AMSILK ANNOUNCES SUCCESSFUL PARTNERSHIP NEGOTIATION WITH AJINOMOTO FOR INDUSTRIAL FERMENTATION
OCTOBER 16, 2024
LINK
Neuried, Germany, 16 October 2024: AMSilk GmbH (“AMSilk/the Company”), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that the Company and Ajinomoto Foods Europe (AFE), a company with over 50 years of experience in industrial fermentation, and the affiliate of the globally established Ajinomoto group, have expressed mutual interest to step into a long-term partnership to biomanufacture silk proteins at Ajinomoto Foods Europe’s manufacturing facility in Nesle, France.
AMSilk is forming a strategic collaboration with Ajinomoto, leveraging Ajinomoto’s extensive industrial expertise in precision fermentation and its strategically located site in France. The facility, in the vicinity of AMSilk’s key customers in the premium textile and consumer goods industries, is backwardly integrated with local raw materials and renewable energy, aligning perfectly with AMSilk’s commitment to sustainable business practices.
This partnership marks a significant step for AMSilk as it rapidly progresses towards becoming a commercial supplier of spider silk-based proteins. By harnessing Ajinomotos’s global fabrication capabilities and state-of-the-art facilities, AMSilk is well-positioned to achieve its commercial milestones and further its mission of delivering high-performance biotech materials on a large scale.
Hiroshi Kaneko, President Ajinomoto Foods Europe: “We are thrilled to partner with AMSilk and are committed to accelerating the market development of their innovative products by supporting their large-scale biomanufacturing efforts. Together, we aspire to create a substantial economic and social impact while driving global innovation forward.”
Ulrich Scherbel, Chief Executive Officer at AMSilk comments: “As a global player with longstanding expertise, Ajinomoto is an ideal production partner for us. Their premier fermentation capabilities in France enable us to meet the demands of our European customers by providing nearshored, high-quality materials.”
AMSilk provides disruptive material solutions to enable the world’s leading brands to address their carbon footprint. Its protein formulations do not contain any substances of animal origin or fossil-based raw materials and leave no microplastics behind. At the end of their life, they are verifiably biodegradable or recyclable. Being biofabricated, these materials can be tailored at a molecular level to specific markets or product requirements.
TRUISM
1 month ago
(INITIAL INSIDER HOLDINGS REPORT) OF FILED (08/15/2024)
SEC.GOV
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Nardi Cintia
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Naffakh Sami Pascal
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 FIDDLER JERRY
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Finard Jeri B
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Carpio Ransley Keoni
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Steefel Daniel Patrick
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 KLOSK STEVEN M
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 Barth Brett H
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 Dean Lloyd H
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 Breslauer David Nate
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2023-03-16 Doft Jacob
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2023-03-16 Hirt Lance L.
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4/A (Insider trading report) 2024-08-21 2023-03-16 Golden Arrow Sponsor, LLC
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Befumo Randy
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Slattery Paul Joseph
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Breslauer David Nate
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 FIDDLER JERRY
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2023-03-16 Golden Arrow Sponsor, LLC
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2023-03-16 Babich Timothy C
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 van den Boom Esther
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
3 (Initial insider holdings report) 2024-08-15 2024-08-13 Widmaier Daniel Matthew
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 Widmaier Daniel Matthew
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
8-K (Current report) 2024-08-19 2024-08-13 Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 Nardi Cintia
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 HIDARY JACK
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2024-08-13 Befumo Randy
Bolt Projects Holdings, Inc. (BSLK, BSLKW)
4 (Insider trading report) 2024-08-15 2023-03-16 RECHTSCHAFFEN ANDREW
Bolt Projects Holdings, Inc. (BSLK, BSLKW)